Richter, Mochida To Move Ahead On European, Japanese Tocilizumab Filings
Positive Topline Phase I And Phase III Data Brings Major Filings Within View
Hungary’s Gedeon Richter and its Japanese partner Mochida have together unveiled plans to file their proposed Actemra/RoActemra biosimilar with major regulators, after biosimilar competition to the IL-6 receptor inhibitor materialized in the US last year.
